OVI Partners
Overview
OVI Partners is a venture capital firm based in Seattle that also operates a tech startup accelerator program, focusing on investments in deep tech sectors such as physical artificial intelligence, robotics, and drones.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arbor Biotechnologies | Nov 2021 | Series B | - |
| Mediar Therapeutics | Mar 2023 | Series A | - |
| Alchemab Therapeutics | Sep 2025 | Series A Extension | - |
| Violet Therapeutics | May 2023 | Seed | - |
| Switch Therapeutics | Mar 2023 | Series A | - |
For institutional investors. Book with your work email.
Key People
Morris K.
Founding Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is OVI Partners based?
OVI Partners is headquartered in Seattle, Washington, United States.
When was OVI Partners founded?
OVI Partners was founded in 2025.
How many portfolio companies does OVI Partners have?
OVI Partners has 10 portfolio companies in Caplight's dataset.
What are some companies in OVI Partners's portfolio?
Portfolio companies visible on Caplight include Arbor Biotechnologies, Mediar Therapeutics, Alchemab Therapeutics, Violet Therapeutics, Switch Therapeutics.
What was OVI Partners's most recent investment shown here?
OVI Partners's most recent investment in this portfolio sample was in Alchemab Therapeutics in 2025.
What sectors does OVI Partners focus on?
OVI Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does OVI Partners focus on?
Stage focus information for OVI Partners is not publicly available.